Healthcare - Biotechnology - NASDAQ - US
$ 1.79
-3.76 %
$ 391 M
Market Cap
-8.14
P/E
Price Target
Average
235.20%
Revenue Forecast
Estimate
25.55%
EBIT
Estimate
--62.63%
Net Income
Estimate
51.23%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Akebia Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AKBA of $6 , with forecasts ranging from a low of $6 to a high of $6 .
AKBA Lowest Price Target
Wall Street Target
6 USD
235.20%
AKBA Average Price Target
Wall Street Target
6 USD
235.20%
AKBA Highest Price Target
Wall Street Target
6 USD
235.20%
REVENUE FORECAST
Revenue Forecast Chart AKBA
EBIT FORECAST
EBIT Forecast Chart AKBA
NET INCOME FORECAST
Net Income Chart AKBA